PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

This study has been completed.
Sponsor:
Collaborator:
Calgary Health Region
Information provided by:
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00530283
First received: September 13, 2007
Last updated: January 18, 2012
Last verified: August 2011
  Purpose

Patients with squamous cell cancer of neck nodes but unknown primary will have a PET-CT scan prior to biopsies. The utility of PET-CT will be determined in this subset of patients.


Condition Intervention
Squamous Cell Cancer
Other: PET-CT

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Clinical Utility of PET-CT in the Management of Squamous Cell Carcinoma of the Neck Nodes With Unknown Primary Malignancy

Resource links provided by NLM:


Further study details as provided by AHS Cancer Control Alberta:

Estimated Enrollment: 58
Study Start Date: August 2007
Study Completion Date: July 2011
Groups/Cohorts Assigned Interventions
A
Patients with Squamous cell cancer of neck nodes, unknown primary
Other: PET-CT

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

18 years

Criteria

Inclusion Criteria:

  • squamous cell cancer of neck nodes with unknown primary site

Exclusion Criteria:

  • unable to tolerate PET-CT
  • unable to undergo examination under anaesthesia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00530283

Locations
Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
Sponsors and Collaborators
AHS Cancer Control Alberta
Calgary Health Region
Investigators
Principal Investigator: Harold Lau, M.D. AHS Cancer Control Alberta
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00530283     History of Changes
Other Study ID Numbers: 20682
Study First Received: September 13, 2007
Last Updated: January 18, 2012
Health Authority: Canada: Alberta Cancer Board

Keywords provided by AHS Cancer Control Alberta:
Squamous
Unknown Primary
Patients with Squamous cell cancer neck nodes

Additional relevant MeSH terms:
Carcinoma, Squamous Cell
Neoplasms, Squamous Cell
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on September 16, 2014